Navigation Links
Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
Date:7/29/2008

RICHMOND, Calif., July 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic development programs and an overview of the company's business strategy at 3:00 p.m. (ET) on Tuesday, August 5, 2008, at the BMO Capital Markets Focus on Healthcare Conference in New York City.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy. Other therapeutic development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
2. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
3. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
4. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
6. Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
7. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
8. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
9. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
10. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
11. Sangamo BioSciences to Present at the Cowen and Company 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... RedBrick Health , a fast-growing leader in consumer ... EmblemHealth , the New York ... the RedBrick Compass health assessment, combined with the RedBrick ... members. EmblemHealth is among the first health plans in ...
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA theory ... of these latent viruses is the Epstein Barr Virus (EBV), ... arthritis (RA) is a chronic inflammatory disease that destroys the ... that RA patients have high concentrations of EBV DNA in ...
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
(Date:1/14/2014)... 2014 As pet owners drew up their lists of New ... "Take better care of my furry companion." Nowadays there are pet ... carrying cases to take the little canine or feline darlings along ... to buy some pricey toys at the pet store. But anyone ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... seems clear that the first thing to do when draining ... The same applies to an information swamp. Information not only ... leaks in, but also as its passed within an organization. ... connections, distributed ERP systems and even the old, back office ...
... Gas and Electric (MG&E) awarded Intergraph ... to upgrade its existing FRAMME-based AM/FM/GIS application to ... is scheduled for May. , ,G/Technology will provide ... (GRM) environment and includes solutions designed to streamline ...
... NeuronFarm LLC , a privately held Madison, Wisconsin-based educational ... to introduce its products designed for students, educators and ... www.NeuronFarm.com ) provides information about The NeuronFarms e-learning literacy ... to aid struggling readers to how to self-monitor higher ...
Cached Biology Technology:Draining the Information Swamp 2Draining the Information Swamp 3NeuronFarm announces literacy training website 2
(Date:7/9/2014)... found in the bladders of healthy women differ ... of incontinence, according to researchers from Loyola University ... findings, published July 9, 2014, in the American ... suggest that bacterial communities may play a role ... (UUI) is a common, yet poorly understood, condition ...
(Date:7/9/2014)... in Indiana state parks have helped restore the health ... overabundant populations of white-tailed deer, a Purdue study shows. ... professor of forest ecology, found that a 17-year-long Indiana ... state parks has successfully spurred the regrowth of native ... deer. , Jenkins said that while hunting may ...
(Date:7/9/2014)... Sexual selection refers to species, selection for traits that ... of natural selection enhances opportunities to mate, the tail ... at the University of California, Riverside have now found ... a placenta are linked. Describing the life histories ... family Poeciliidae, the researchers found that species with placentas ...
Breaking Biology News(10 mins):Hunting gives deer-damaged forests in state parks a shot at recovery 2Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4
... the cell, gateways through which critical signals and chemicals are ... gateways -- proteins that span the cell membrane and connect ... remain, for the most part, black boxes with little ... of intense interest to scientists as they are the targets ...
... Oct. 30, 2010 Researchers at the Institute for Regenerative ... an early, but important, milestone in the quest to grow ... use human liver cells to successfully engineer miniature livers that ... human livers. The next step is to see if the ...
... flies by masquerading as mushrooms. Goblin spiders lurk unseen in ... as haunting as the macabre costumes worn on city streets, ... in the Division of Invertebrate Zoology at the American Museum ... DRACULA ORCHIDS ,According to Grimaldi and colleagues, fruit ...
Cached Biology News:Chemists concoct new agents to easily study critical cell proteins 2Researchers engineer miniature human livers in the lab 2Dracula orchids and goblin spiders 2Dracula orchids and goblin spiders 3
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
...
AADAC Immunogen: AADAC (NP_001077, 201 a.a. ~ 301 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
WTAP Antibody...
Biology Products: